Neoplasms, Hepatic Completed Phase 1 Trials for Floxuridine (DB00322)

Also known as: Hepatic Tumor / Hepatic Tumors / Tumors in Liver / Liver Neoplasm / Liver Neoplasms / Neoplasms, Liver / Liver Tumours / Neoplasm, Liver / Tumor Liver / Liver Tumors / Liver Tumor / Liver Tumour / Hepatic Neoplasms / Hepatic Neoplasm / Neoplasm, Hepatic / Liver cell carcinoma / Liver tumour NOS / Liver tumor NOS / Tumour liver / Hepatic neoplasm NOS / Neoplasm of liver (disorder) / Neoplasm liver / Hepatic neoplasia

IndicationStatusPhase
DBCOND0040277 (Neoplasms, Hepatic)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001576A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the LiverTreatment